1. Home
  2. LPCN
  3. LPCN News

Latest Lipocine Inc. (LPCN) News on November 25, 2025

Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)
LPCN

PR Newswire

7 days ago

Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Lipocine (LPCN) Reports Q3 Loss, Tops Revenue Estimates
LPCN

Zacks

19 days ago

Lipocine (LPCN) Reports Q3 Loss, Tops Revenue Estimates

LPCN

Associated Press Finance

19 days ago

Lipocine: Q3 Earnings Snapshot

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025
LPCN

PR Newswire

19 days ago

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025

Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek®
LPCN

PR Newswire

21 days ago

Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek®

Lipocine Announces First Patient Dosed in Phase 3 Clinical Trial for LPCN 1154 in Postpartum Depression
LPCN

PR Newswire

5 months ago

Lipocine Announces First Patient Dosed in Phase 3 Clinical Trial for LPCN 1154 in Postpartum Depression

Lipocine to Host Virtual R&D Investor Event to Discuss LPCN 1154 (BRLIZIO™) as a Treatment for Postpartum Depression on July 9, 2025
LPCN

PR Newswire

5 months ago

Lipocine to Host Virtual R&D Investor Event to Discuss LPCN 1154 (BRLIZIO™) as a Treatment for Postpartum Depression on July 9, 2025

Lipocine Announces Filing of New Drug Submission for TLANDO® in Canada
LPCN

PR Newswire

6 months ago

Lipocine Announces Filing of New Drug Submission for TLANDO® in Canada

Lipocine's LPCN 1148 Highlighted in the June 2025 Edition of Hepatology
LPCN

PR Newswire

6 months ago

Lipocine's LPCN 1148 Highlighted in the June 2025 Edition of Hepatology

Lipocine to Present at A.G.P.'s Annual Healthcare Company Showcase
LPCN

PR Newswire

6 months ago

Lipocine to Present at A.G.P.'s Annual Healthcare Company Showcase

LPCN

Associated Press Finance

7 months ago

Lipocine: Q1 Earnings Snapshot

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2025
LPCN

PR Newswire

7 months ago

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2025

Lipocine Announces License and Supply Agreement for TLANDO® in Brazil
LPCN

PR Newswire

7 months ago

Lipocine Announces License and Supply Agreement for TLANDO® in Brazil

Lipocine’s Phase III trial of LPCN 1154 to begin for postpartum depression
LPCN

Clinical Trials Arena

8 months ago

Lipocine’s Phase III trial of LPCN 1154 to begin for postpartum depression

Lipocine Announces Initiation of Outpatient Phase 3 Postpartum Depression Trial of LPCN 1154
LPCN

PR Newswire

8 months ago

Lipocine Announces Initiation of Outpatient Phase 3 Postpartum Depression Trial of LPCN 1154

Lipocine Announces Financial Results for the Full Year Ended December 31, 2024
LPCN

PR Newswire

8 months ago

Lipocine Announces Financial Results for the Full Year Ended December 31, 2024

Lipocine Announces FDA Labeling Changes for Testosterone Products
LPCN

PR Newswire

8 months ago

Lipocine Announces FDA Labeling Changes for Testosterone Products

Lipocine Receives Updated Regulatory Guidance on LPCN 1154
LPCN

PR Newswire

10 months ago

Lipocine Receives Updated Regulatory Guidance on LPCN 1154

LPCN

MT Newswires

a year ago

Sector Update: Health Care

LPCN

MT Newswires

a year ago

Lipocine Says LPCN 1148 Gets FDA Fast Track Label

FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis
LPCN

PR Newswire

a year ago

FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis

Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session
LPCN

PR Newswire

a year ago

Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024
LPCN

PR Newswire

a year ago

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024

LPCN

Associated Press Finance

a year ago

Lipocine: Q3 Earnings Snapshot

Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea
LPCN

PR Newswire

a year ago

Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea

Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results
LPCN

PR Newswire

a year ago

Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results

Lipocine signs supply and distribution agreement with Pharmalink for Tlando
LPCN

TipRanks

a year ago

Lipocine signs supply and distribution agreement with Pharmalink for Tlando

LPCN

MT Newswires

a year ago

Lipocine Signs Exclusive Tlando Supply, Distribution Deal With Pharmalink

Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries
LPCN

PR Newswire

a year ago

Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries

Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024
LPCN

PR Newswire

a year ago

Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024

Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference
LPCN

PR Newswire

a year ago

Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference

Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek®
LPCN

PR Newswire

a year ago

Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek®

Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference
LPCN

PR Newswire

a year ago

Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2024
LPCN

PR Newswire

a year ago

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2024

LPCN

Associated Press Finance

a year ago

Lipocine: Q2 Earnings Snapshot

Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal Study
LPCN

PR Newswire

a year ago

Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal Study

Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024
LPCN

PR Newswire

a year ago

Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024

Lipocine (LPCN) Is a Great Choice for 'Trend' Investors, Here's Why
LPCN

Zacks

a year ago

Lipocine (LPCN) Is a Great Choice for 'Trend' Investors, Here's Why

Here's Why Momentum in Lipocine (LPCN) Should Keep going
LPCN

Zacks

2 years ago

Here's Why Momentum in Lipocine (LPCN) Should Keep going

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024
LPCN

PR Newswire

2 years ago

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024

LPCN

Associated Press Finance

2 years ago

Lipocine: Q1 Earnings Snapshot

Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024
LPCN

PR Newswire

2 years ago

Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024

Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154
LPCN

PR Newswire

2 years ago

Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154

Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
LPCN

PR Newswire

2 years ago

Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity

Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis
LPCN

PR Newswire

2 years ago

Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis

Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154
LPCN

PR Newswire

2 years ago

Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154

Lipocine Announces Financial Results for the Full Year Ended December 31, 2023
LPCN

PR Newswire

2 years ago

Lipocine Announces Financial Results for the Full Year Ended December 31, 2023

Lipocine to Present at 36th Annual Roth Conference
LPCN

PR Newswire

2 years ago

Lipocine to Present at 36th Annual Roth Conference

Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154
LPCN

PR Newswire

2 years ago

Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154

Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals
LPCN

PR Newswire

2 years ago

Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals

5E Advanced Materials Closes Second Tranche of Equity Financing
LPCN

GlobeNewswire

2 years ago

5E Advanced Materials Closes Second Tranche of Equity Financing

eFFECTOR Therapeutics Announces Closing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
LPCN

GlobeNewswire

2 years ago

eFFECTOR Therapeutics Announces Closing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

7 Stocks to Buy Now for Massive Growth Potential in 2024
LPCN

InvestorPlace

2 years ago

7 Stocks to Buy Now for Massive Growth Potential in 2024

LPCN

GlobeNewswire

2 years ago

QuantaSing Announces Appointment of New Independent Director

Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and Canada
LPCN

PR Newswire

2 years ago

Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and Canada

QuantaSing Unveils Private Label Chinese Baijiu Brand YUNTING
LPCN

PR Newswire

2 years ago

QuantaSing Unveils Private Label Chinese Baijiu Brand YUNTING

KULR Secures Exclusive Global License for NASA’s Battery Safety Technology to Service World’s Largest OEM Customers
LPCN

GlobeNewswire

2 years ago

KULR Secures Exclusive Global License for NASA’s Battery Safety Technology to Service World’s Largest OEM Customers

LPCN

Business Wire

2 years ago

Pagaya Announces Strategic Actions to Enhance Marketability of its Stock, Strong Financial Outperformance in 4Q23 and FY23

7 A-Rated Semiconductor Stocks to Buy in January
LPCN

InvestorPlace

2 years ago

7 A-Rated Semiconductor Stocks to Buy in January

Lichen China Limited's (NASDAQ:LICN) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
LPCN

Simply Wall St.

2 years ago

Lichen China Limited's (NASDAQ:LICN) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Denali Capital Acquisition Corp. Announces Postponement of Extraordinary General Meeting From Thursday, January 4, 2024 to Tuesday, January 9, 2024
LPCN

PR Newswire

2 years ago

Denali Capital Acquisition Corp. Announces Postponement of Extraordinary General Meeting From Thursday, January 4, 2024 to Tuesday, January 9, 2024

NKGen Biotech Advances Alzheimer's Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial
LPCN

News Direct

2 years ago

NKGen Biotech Advances Alzheimer's Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

We're Keeping An Eye On NeoVolta's (NASDAQ:NEOV) Cash Burn Rate
LPCN

Simply Wall St.

2 years ago

We're Keeping An Eye On NeoVolta's (NASDAQ:NEOV) Cash Burn Rate

Lipocine to Present at Biotech Showcase 2024
LPCN

PR Newswire

2 years ago

Lipocine to Present at Biotech Showcase 2024

Pagaya Technologies Ltd.'s (NASDAQ:PGY) market cap up US$85m last week, benefiting both retail investors who own 25% as well as insiders
LPCN

Simply Wall St.

2 years ago

Pagaya Technologies Ltd.'s (NASDAQ:PGY) market cap up US$85m last week, benefiting both retail investors who own 25% as well as insiders

LPCN

Business Wire

2 years ago

Pagaya Announces Partnership with Exeter Finance, Further Scaling its Auto Lending Product

Under The Bonnet, iHuman's (NYSE:IH) Returns Look Impressive
LPCN

Simply Wall St.

2 years ago

Under The Bonnet, iHuman's (NYSE:IH) Returns Look Impressive

LPCN

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Burning Rock Biotech Ltd Earnings Call

Burning Rock Reports Third Quarter 2023 Financial Results
LPCN

GlobeNewswire

2 years ago

Burning Rock Reports Third Quarter 2023 Financial Results

Pagaya Technologies Names Former Xerox Executive Nicole Torraco to its Board of Directors
LPCN

Business Wire

2 years ago

Pagaya Technologies Names Former Xerox Executive Nicole Torraco to its Board of Directors

LPCN

PR Newswire

2 years ago

iClick Interactive Asia Group Limited Enters into a Definitive Merger Agreement for Going-Private Transaction

CPI Aerostructures Receives $4.4M Orders from Embraer for Engine Inlet Assemblies
LPCN

GlobeNewswire

2 years ago

CPI Aerostructures Receives $4.4M Orders from Embraer for Engine Inlet Assemblies

LPCN

PR Newswire

2 years ago

Prenetics Announces Third Quarter 2023 Financial Results

We're Not Very Worried About CervoMed's (NASDAQ:CRVO) Cash Burn Rate
LPCN

Simply Wall St.

2 years ago

We're Not Very Worried About CervoMed's (NASDAQ:CRVO) Cash Burn Rate

Arqit Sets Fiscal Year 2023 Conference Call for Tuesday, November 21, 2023 at 11:00 a.m. ET
LPCN

GlobeNewswire

2 years ago

Arqit Sets Fiscal Year 2023 Conference Call for Tuesday, November 21, 2023 at 11:00 a.m. ET

LPCN

Thomson Reuters StreetEvents

2 years ago

Q3 2023 BioXcel Therapeutics Inc Earnings Call

LPCN

GuruFocus.com

2 years ago

Reneo Pharmaceuticals Inc (RPHM) Reports Q3 2023 Financial Results

Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks
LPCN

Insider Monkey

2 years ago

Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks

Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver Meeting® 2023
LPCN

PR Newswire

2 years ago

Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver Meeting® 2023

Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results
LPCN

GlobeNewswire

2 years ago

Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results

Prenetics Global Limited (NASDAQ:PRE): Is Breakeven Near?
LPCN

Simply Wall St.

2 years ago

Prenetics Global Limited (NASDAQ:PRE): Is Breakeven Near?

PLBY Group, Inc. (NASDAQ:PLBY) Q3 2023 Earnings Call Transcript
LPCN

Insider Monkey

2 years ago

PLBY Group, Inc. (NASDAQ:PLBY) Q3 2023 Earnings Call Transcript

Synchronoss Technologies, Inc. (NASDAQ:SNCR) Q3 2023 Earnings Call Transcript
LPCN

Insider Monkey

2 years ago

Synchronoss Technologies, Inc. (NASDAQ:SNCR) Q3 2023 Earnings Call Transcript

LPCN

Associated Press Finance

2 years ago

Lipocine: Q3 Earnings Snapshot

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023
LPCN

PR Newswire

2 years ago

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023

LPCN

Associated Press Finance

2 years ago

Western Copper: Q3 Earnings Snapshot

LPCN

ACCESSWIRE

2 years ago

TG Venture Acquisition Corp. Announces Stockholder Approval of Extension Amendment to the Amended and Restated Certificate of Incorporation and Investment Management Trust Agreement

Curo Group (CURO) Reports Q3 Loss, Lags Revenue Estimates
LPCN

Zacks

2 years ago

Curo Group (CURO) Reports Q3 Loss, Lags Revenue Estimates

REE Automotive Regains Compliance with Nasdaq Minimum Bid Price Requirement
LPCN

GlobeNewswire

2 years ago

REE Automotive Regains Compliance with Nasdaq Minimum Bid Price Requirement

Prenetics Global Limited Announces Reverse Stock Split
LPCN

GlobeNewswire

2 years ago

Prenetics Global Limited Announces Reverse Stock Split

Stabilis Solutions Announces Multi-Year LNG Bunkering Contract with Carnival Corporation
LPCN

ACCESSWIRE

2 years ago

Stabilis Solutions Announces Multi-Year LNG Bunkering Contract with Carnival Corporation

Share on Social Networks: